Thompson Investment Management Inc. Sells 250 Shares of Colgate-Palmolive (NYSE:CL)

Share on StockTwits

Thompson Investment Management Inc. cut its holdings in shares of Colgate-Palmolive (NYSE:CL) by 4.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,620 shares of the company’s stock after selling 250 shares during the period. Thompson Investment Management Inc.’s holdings in Colgate-Palmolive were worth $403,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of the business. Northern Trust Corp lifted its holdings in shares of Colgate-Palmolive by 1.4% in the first quarter. Northern Trust Corp now owns 10,906,808 shares of the company’s stock valued at $747,553,000 after purchasing an additional 146,144 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Colgate-Palmolive by 7.9% in the fourth quarter. Geode Capital Management LLC now owns 10,540,277 shares of the company’s stock valued at $626,200,000 after purchasing an additional 768,550 shares in the last quarter. FIL Ltd lifted its holdings in shares of Colgate-Palmolive by 9.6% in the first quarter. FIL Ltd now owns 7,972,928 shares of the company’s stock valued at $546,465,000 after purchasing an additional 695,987 shares in the last quarter. FMR LLC lifted its holdings in shares of Colgate-Palmolive by 29.1% in the first quarter. FMR LLC now owns 7,384,604 shares of the company’s stock valued at $506,141,000 after purchasing an additional 1,665,348 shares in the last quarter. Finally, OppenheimerFunds Inc. lifted its holdings in shares of Colgate-Palmolive by 2.5% in the first quarter. OppenheimerFunds Inc. now owns 5,855,519 shares of the company’s stock valued at $401,337,000 after purchasing an additional 142,293 shares in the last quarter. Hedge funds and other institutional investors own 75.83% of the company’s stock.

In other news, VP Philip G. Shotts sold 8,919 shares of the company’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $71.05, for a total value of $633,694.95. Following the transaction, the vice president now owns 50,399 shares of the company’s stock, valued at $3,580,848.95. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Ian M. Cook sold 19,500 shares of the company’s stock in a transaction that occurred on Wednesday, May 29th. The shares were sold at an average price of $69.92, for a total value of $1,363,440.00. Following the completion of the transaction, the insider now directly owns 1,186,042 shares in the company, valued at approximately $82,928,056.64. The disclosure for this sale can be found here. In the last three months, insiders have sold 564,285 shares of company stock worth $40,530,290. Company insiders own 1.14% of the company’s stock.

Shares of NYSE:CL traded up $0.48 during midday trading on Tuesday, reaching $73.26. The company had a trading volume of 769,755 shares, compared to its average volume of 3,551,955. The company has a quick ratio of 0.78, a current ratio of 1.13 and a debt-to-equity ratio of 32.25. The business’s 50 day moving average price is $72.52 and its 200 day moving average price is $70.22. The stock has a market cap of $61.97 billion, a PE ratio of 24.66, a P/E/G ratio of 4.65 and a beta of 0.76. Colgate-Palmolive has a 1-year low of $57.41 and a 1-year high of $76.41.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, July 26th. The company reported $0.72 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.72. The business had revenue of $3.87 billion for the quarter, compared to the consensus estimate of $3.88 billion. Colgate-Palmolive had a negative return on equity of 10,821.98% and a net margin of 14.77%. Colgate-Palmolive’s quarterly revenue was down .5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.77 earnings per share. On average, research analysts expect that Colgate-Palmolive will post 2.84 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Thursday, July 18th were given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 2.35%. The ex-dividend date of this dividend was Wednesday, July 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.91%.

A number of analysts have recently commented on CL shares. Macquarie boosted their price target on Colgate-Palmolive from $65.00 to $72.00 and gave the company a “neutral” rating in a report on Monday, April 29th. Jefferies Financial Group boosted their price target on Colgate-Palmolive from $61.00 to $73.00 and gave the company an “in-line” rating in a report on Monday, April 29th. They noted that the move was a valuation call. Bank of America set a $80.00 price target on Colgate-Palmolive and gave the company a “buy” rating in a report on Friday, July 12th. Morgan Stanley boosted their price target on Colgate-Palmolive from $72.00 to $74.00 and gave the company an “equal weight” rating in a report on Monday, July 29th. Finally, Piper Jaffray Companies started coverage on Colgate-Palmolive in a report on Tuesday, August 13th. They issued an “overweight” rating on the stock. One research analyst has rated the stock with a sell rating, twelve have given a hold rating and six have issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $73.87.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Featured Article: G-20

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.